Personalis Inc. Common Stock vs Rocket Companies Inc. Class A Common Stock — how do they compare? Personalis Inc. Common Stock trades at $15.75 (market cap $1.70B), while Rocket Companies Inc. Class A Common Stock trades at $10.84 (market cap $29.82B). The key difference: Rocket Companies Inc. Class A Common Stock is far larger — about 17.5× Personalis Inc. Common Stock's market cap, and Personalis Inc. Common Stock is trading nearer its 52-week high, Rocket Companies Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Personalis Inc. Common Stock for 0 Days and Rocket Companies Inc. Class A Common Stock for 0 Days on average.
| PSNL | RKT | |
|---|---|---|
Market Cap | $1.70B | $29.82B |
Volume | 3,262,398 | 46,995,062 |
Sector | Health | Financials |
52-Week High | $18.38 | $23.44 |
52-Week Low | $5.04 | $10.53 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.52B | $59.81B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Rocket Companies (RKT) trades at $10.83, down 0.37% on the day, with a neutral technical signal and mixed earnings history. The stock is near its 52-week low amid a challenging mortgage market. Recent financials show a net loss of $68 million in 2025 but project a return to profitability in 2026. Analyst consensus is a 'Buy' with a $16.88 price target, though sentiment is tempered by high interest rates and housing market pressures.
Outlook: RKT offers potential upside from current depressed levels if mortgage demand recovers, but faces significant headwinds from persistent high rates and weak housing activity. Risks include competitive pressures and regulatory scrutiny, while opportunities lie in market share gains and cost management improvements. Investors should weigh the cyclical recovery potential against near-term macroeconomic challenges.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Personalis Inc. is a cancer genomics company that provides tumor- and blood-based DNA and RNA sequencing tests, including its NeXT Personal liquid biopsy test for cancer monitoring.
Read more on PSNL →Rocket Companies, Inc. operates a homeownership platform spanning mortgage origination and servicing, real estate, title and closing, and personal finance, with flagship brands including Rocket Mortgage, Rocket Close, Rocket Money, Rocket Loans, and Redfin.
Read more on RKT →